Clinical Trial Details
Trial ID: | L1872 |
Source ID: | NCT03594591 |
Associated Drug: | Antidiabetic Treatment By Usual Care |
Title: | Changes in the Retinal and Carotid Microcirculation After Restoring Normoglycemia in Patients With Type 2 Diabetes |
Acronym: | OCTAUS-T2D |
Status: | UNKNOWN |
Study Results: | NO |
Results: | |
Conditions: | Type 2 Diabetes Mellitus|Microangiopathy|Diabetic Retinopathy|Arteriosclerosis|Carotid Atherosclerosis |
Interventions: | DRUG: Antidiabetic treatment by usual care |
Outcome Measures: | Primary: Changes in retinal microcirculation (perifoveal vessel density), Changes in perifoveal vessel density, OCTA images will be processed to obtain vascular density measurements in this area (mm-1), 0, 1, 3 and 6 months|Changes in arterial wall microcirculation (vasa-vasorum density), Changes vasa-vasorum (VV) density, VV signal as the ratio of the contrast agent signal of the VV and that of the lumen of the artery, 0, 3 and 6 months | Secondary: Changes in retinal microcirculation (Parafoveal vessel density ), OCTA images will be processed to obtain vascular density measurements in this area (mm-1), 0, 1, 3 and 6 months|Changes in retinal microcirculation (Total Avascular Area ), OCTA images will be processed to obtain total avascular area measurements (mm2), 0, 1, 3 and 6 months|Changes in retinal microcirculation (Foveal Avascular Area), OCTA images will be processed to obtain foveal avascular zone area measurements (mm2), 0, 1, 3 and 6 months |
Sponsor/Collaborators: | Sponsor: Hospital Clinic of Barcelona | Collaborators: Instituto de Salud Carlos III|Institut d'Investigacions Biomèdiques August Pi i Sunyer |
Gender: | ALL |
Age: | ADULT, OLDER_ADULT |
Phases: | |
Enrollment: | 20 |
Study Type: | OBSERVATIONAL |
Study Designs: | Observational Model: |Time Perspective: p |
Start Date: | 2018-01-02 |
Completion Date: | 2020-01-01 |
Results First Posted: | |
Last Update Posted: | 2018-07-24 |
Locations: | Hospital Clínic de Barcelona, Barcelona, 08036, Spain |
URL: | https://clinicaltrials.gov/show/NCT03594591 |

Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
---|